1. [Soft tissue infections].
- Author
-
Rongisch R and Fabri M
- Subjects
- Anti-Bacterial Agents therapeutic use, Cellulitis drug therapy, Cellulitis microbiology, Humans, Erysipelas diagnosis, Erysipelas drug therapy, Skin Diseases, Bacterial diagnosis, Skin Diseases, Bacterial drug therapy, Skin Diseases, Infectious diagnosis, Skin Diseases, Infectious drug therapy, Soft Tissue Infections diagnosis, Soft Tissue Infections drug therapy, Staphylococcal Infections
- Abstract
Acute skin and soft tissue infections are among the most frequent infections in medicine. There is a broad spectrum including simple local infections as well as severe and life-threatening diseases. Along with Staphylococcus aureus, group A Streptococci are mainly responsible for these illnesses. The therapeutic approach ranges from antiseptic local treatments to administering systemic antibiotics or emergency surgery. Treating physicians often face challenges when presented with soft tissue infections due to a great discrepancy between the first impression of the disease compared to a possibly quick progression as well as the wide range of sometimes confusing historic terms and definitions being used in the English and German language, for instance pyoderma, erysipelas or phlegmon. A recently more popular collective term emphasized by clinical trials is "acute bacterial skin and skin structure infections" (ABSSSI)., (© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF